The patient's genetic findings, including the presence of an atypical EWSR1::FLI1 fusion and a possible cancer predisposition due to a CHEK2 variant, further complicate the clinical picture, necessitating a more nuanced treatment approach. Here, EWSR1 is linked to cancer.